Evangelos Terpos (E Terpos)

ORCID

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 198

Top Venues

American journal of hematology

Cancers

International journal of molecular sciences

Journal of clinical medicine

National and Kapodistrian University of Athens - Faculty of Medicine

National and Kapodistrian University of Athens - Faculty of Medicine (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

National and Kapodistrian University of Athens - Faculty of Medicine Jul 17 2018

Greece

Professor of Hematology :: Department of Clinical Therapeutics

Imperial College London - Dec 31 2018

United Kingdom

Honorary Senior Lecturer :: Department of Hematology

National and Kapodistrian University of Athens - Faculty of Medicine Feb 19 2014 - Jul 17 2018

Greece

Associate Professor for Hematology :: Department of Clinical Therapeutics

National and Kapodistrian University of Athens - Faculty of Medicine Oct 09 2009 - Feb 18 2014

Greece

Assistant Professor for Hematology :: Department of Clinical Therapeutics

251 General Air Force Hospital Oct 04 2003 - Oct 08 2009

Greece

Consultant Hematologist :: Department of Hematology

Imperial College London Oct 01 2001 - Oct 03 2003

United Kingdom

Honorary Consultant Hematologist :: Department of Hematology

251 General Air Force Hospital Feb 01 2000 - Sep 17 2001

Greece

Consultant Hematologist :: Department of Hematology

Education History

National and Kapodistrian University of Athens - Faculty of Medicine Apr 20 1997 - Oct 18 2002

Greece

PHD :: First Department of Medicine

Publications

Panagiotis Malamos, Christina Papanikolaou, Maria Gavriatopoulou, Meletios- Athanasios Dimopoulos, Evangelos Terpos, Vassilis L Souliotis
The Interplay between the DNA Damage Response (DDR) Network and the Mitogen-Activated Protein Kinase (MAPK) Signaling Pathway in Multiple Myeloma. International journal of molecular sciences 25 (13) (2024)
Ioannis V Kostopoulos, Despina Fotiou, Maria Gavriatopoulou, Pantelis Rousakis, Ioannis Ntanasis-Stathopoulos, Chrysanthi Panteli, Panagiotis Malandrakis, Magdalini Migkou, Nikolaos Angelis, Nikolaos Kanellias, Evangelos Eleutherakis-Papaiakovou, Foteini Theodorakakou, Maria Krevvata, Evangelos Terpos, Meletios- Athanasios Dimopoulos, Ourania E Tsitsilonis, Efstathios Kastritis
Efficacy and immune modulation associated with the addition of IMiDs to Daratumumab backbone in multiple myeloma patients refractory to both drug classes: resetting synergistic activity. Blood cancer journal 14 (1) (2024)
Maria Gavriatopoulou, Ioannis Ntanasis-Stathopoulos, Panagiotis Malandrakis, Despina Fotiou, Magdalini Migkou, Foteini Theodorakakou, Vasiliki Spiliopoulou, Nikolaos Kanellias, Evangelos Eleutherakis-Papaiakovou, Maria Roussou, Giorgos Psarros, Efstathios Kastritis, Meletios- Athanasios Dimopoulos, Evangelos Terpos
Belantamab mafodotin, lenalidomide, and dexamethasone in transplant-ineligible patients with newly diagnosed multiple myeloma: Analysis of belantamab mafodotin-associated ocular adverse events and their impact on daily functioning from the part 1 of a phase 1/2 study. American journal of hematology 99 (3) (2024)
Evangelos Terpos, Ioannis Ntanasis-Stathopoulos, Maria Gavriatopoulou, Eirini Katodritou, Evdoxia Hatjiharissi, Panagiotis Malandrakis, Evgenia Verrou, Stavros Golfinopoulos, Magdalini Migkou, Kyriaki Manousou, Sosana Delimpasi, Argiris Symeonidis, Efstathios Kastritis, Meletios- Athanasios Dimopoulos
Efficacy and safety of daratumumab with ixazomib and dexamethasone in lenalidomide-exposed patients after one prior line of therapy: Final results of the phase 2 study DARIA. American journal of hematology 99 (3) (2024)
Ioannis V Kostopoulos, Despina Fotiou, Maria Gavriatopoulou, Pantelis Rousakis, Ioannis Ntanasis-Stathopoulos, Chrysanthi Panteli, Panagiotis Malandrakis, Magdalini Migkou, Nikolaos Angelis, Nikolaos Kanellias, Evangelos Eleutherakis-Papaiakovou, Foteini Theodorakakou, Maria Krevvata, Evangelos Terpos, Meletios- Athanasios Dimopoulos, Ourania E Tsitsilonis, Efstathios Kastritis
Efficacy and immune modulation associated with the addition of IMiDs to Daratumumab backbone in multiple myeloma patients refractory to both drug classes: resetting synergistic activity. Blood cancer journal 14 (1) (2024)
Despina Fotiou, Foteini Theodorakakou, Sotiria Spiliopoulou, Maria Gavriatopoulou, Magdalini Migkou, Nikolaos Kanellias, Evangelos Eleutherakis-Papaiakovou, Panagiotis Malandrakis, Ioanna Dialoupi, Maria Roussou, Ioannis Ntanasis-Stathopoulos, Evangelos Terpos, Meletios- Athanasios Dimopoulos, Efstathios Kastritis
Thrombotic and bleeding complications in patients with AL amyloidosis. British journal of haematology 204 (5) (2024)
Maria Papatsirou, Christos K Kontos, Ioannis Ntanasis-Stathopoulos, Panagiotis Malandrakis, Foteini Theodorakakou, Christine-Ivy Liacos, Nefeli Mavrianou-Koutsoukou, Despina Fotiou, Magdalini Migkou, Maria Gavriatopoulou, Efstathios Kastritis, Meletios- Athanasios Dimopoulos, Andreas Scorilas, Evangelos Terpos
ciRS-7 circular RNA overexpression in plasma cells is a promising molecular biomarker of unfavorable prognosis in multiple myeloma. EJHaem 5 (4) (2024)
Maria Papatsirou, Christos K Kontos, Ioannis Ntanasis-Stathopoulos, Panagiotis Malandrakis, Diamantis C Sideris, Despina Fotiou, Christine-Ivy Liacos, Maria Gavriatopoulou, Efstathios Kastritis, Meletios A Dimopoulos, Andreas Scorilas, Evangelos Terpos
Exploring the molecular biomarker utility of circCCT3 in multiple myeloma: A favorable prognostic indicator, particularly for R-ISS II patients. HemaSphere 8 (1) (2024)
Ioannis V Kostopoulos, Despina Fotiou, Maria Gavriatopoulou, Pantelis Rousakis, Ioannis Ntanasis-Stathopoulos, Chrysanthi Panteli, Panagiotis Malandrakis, Magdalini Migkou, Nikolaos Angelis, Nikolaos Kanellias, Evangelos Eleutherakis-Papaiakovou, Foteini Theodorakakou, Maria Krevvata, Evangelos Terpos, Meletios- Athanasios Dimopoulos, Ourania E Tsitsilonis, Efstathios Kastritis
Efficacy and immune modulation associated with the addition of IMiDs to Daratumumab backbone in multiple myeloma patients refractory to both drug classes: resetting synergistic activity. Blood cancer journal 14 (1) (2024)
Maria Gavriatopoulou, Ioannis Ntanasis-Stathopoulos, Panagiotis Malandrakis, Despina Fotiou, Magdalini Migkou, Foteini Theodorakakou, Vasiliki Spiliopoulou, Nikolaos Kanellias, Evangelos Eleutherakis-Papaiakovou, Maria Roussou, Giorgos Psarros, Efstathios Kastritis, Meletios- Athanasios Dimopoulos, Evangelos Terpos
Belantamab mafodotin, lenalidomide, and dexamethasone in transplant-ineligible patients with newly diagnosed multiple myeloma: Analysis of belantamab mafodotin-associated ocular adverse events and their impact on daily functioning from the part 1 of a phase 1/2 study. American journal of hematology 99 (3) (2024)
Konstantinos Soureas, Maria-Alexandra Papadimitriou, Panagiotis Malandrakis, Aristea-Maria Papanota, Panagiotis G Adamopoulos, Ioannis Ntanasis-Stathopoulos, Christine-Ivy Liacos, Maria Gavriatopoulou, Diamantis C Sideris, Efstathios Kastritis, Meletios- Athanasios Dimopoulos, Andreas Scorilas, Evangelos Terpos, Margaritis Avgeris
Small RNA-seq and clinical evaluation of tRNA-derived fragments in multiple myeloma: Loss of mitochondrial i-tRF HisGTG results in patients' poor treatment outcome. British journal of haematology (2024)
Maria Papatsirou, Christos K Kontos, Ioannis Ntanasis-Stathopoulos, Panagiotis Malandrakis, Diamantis C Sideris, Despina Fotiou, Christine-Ivy Liacos, Maria Gavriatopoulou, Efstathios Kastritis, Meletios A Dimopoulos, Andreas Scorilas, Evangelos Terpos
Exploring the molecular biomarker utility of circCCT3 in multiple myeloma: A favorable prognostic indicator, particularly for R-ISS II patients. HemaSphere 8 (1) (2024)
Ioannis V Kostopoulos, Ioannis Ntanasis-Stathopoulos, Pantelis Rousakis, Panagiotis Malandrakis, Chrysanthi Panteli, Evangelos Eleutherakis-Papaiakovou, Nikolaos Angelis, Vasiliki Spiliopoulou, Rodanthi-Eleni Syrigou, Panagiotis Bakouros, Georgia Dimitrakopoulou, Despina Fotiou, Magdalini Migkou, Nikolaos Kanellias, Nikolaos Paschalidis, Maria Gavriatopoulou, Efstathios Kastritis, Meletios- Athanasios Dimopoulos, Ourania E Tsitsilonis, Evangelos Terpos
Low circulating tumor cell levels correlate with favorable outcomes and distinct biological features in multiple myeloma. American journal of hematology (2024)
Evangelos Terpos, Ioannis Ntanasis-Stathopoulos, Maria Gavriatopoulou, Eirini Katodritou, Evdoxia Hatjiharissi, Panagiotis Malandrakis, Evgenia Verrou, Stavros Golfinopoulos, Magdalini Migkou, Kyriaki Manousou, Sosana Delimpasi, Argiris Symeonidis, Efstathios Kastritis, Meletios- Athanasios Dimopoulos
Efficacy and safety of daratumumab with ixazomib and dexamethasone in lenalidomide-exposed patients after one prior line of therapy: Final results of the phase 2 study DARIA. American journal of hematology 99 (3) (2024)
Eirini Katodritou, Dimitra Dalampira, Sosana Delimpasi, Ioannis Ntanasis-Stathopoulos, Fryni Karaolidou, Annita-Ioanna Gkioka, Vasiliki Labropoulou, Emmanouil Spanoudakis, Theodora Triantafyllou, Maria Kotsopoulou, Eyrydiki Michalis, Chrysanthi Vadikolia, Theodosia Papadopoulou, Aggeliki Sevastoudi, Michael Michael, Aikaterini Daiou, Aikaterini Pentidou, Ioannis V Kostopoulos, Vasiliki Palaska, Maria Gavriatopoulou, Marie-Christine Kyrtsonis, Evgenia Verrou, Efstathios Kastritis, Meletios- Athanasios Dimopoulos, Evangelos Terpos
Central nervous system multiple myeloma: A real-world multi-institutional study of the Greek Myeloma Study Group. American journal of hematology (2024)
Despina Fotiou, Foteini Theodorakakou, Sotiria Spiliopoulou, Maria Gavriatopoulou, Magdalini Migkou, Nikolaos Kanellias, Evangelos Eleutherakis-Papaiakovou, Panagiotis Malandrakis, Ioanna Dialoupi, Maria Roussou, Ioannis Ntanasis-Stathopoulos, Evangelos Terpos, Meletios- Athanasios Dimopoulos, Efstathios Kastritis
Thrombotic and bleeding complications in patients with AL amyloidosis. British journal of haematology (2024)
Evangelos Terpos, Ioannis Ntanasis-Stathopoulos, Maria Gavriatopoulou, Eirini Katodritou, Evdoxia Hatjiharissi, Panagiotis Malandrakis, Evgenia Verrou, Stavros Golfinopoulos, Magdalini Migkou, Kyriaki Manousou, Sosana Delimpasi, Argiris Symeonidis, Efstathios Kastritis, Meletios- Athanasios Dimopoulos
Efficacy and safety of daratumumab with ixazomib and dexamethasone in lenalidomide-exposed patients after one prior line of therapy: Final results of the phase 2 study DARIA. American journal of hematology (2024)
Maria Gavriatopoulou, Ioannis Ntanasis-Stathopoulos, Panagiotis Malandrakis, Despina Fotiou, Magdalini Migkou, Foteini Theodorakakou, Vasiliki Spiliopoulou, Nikolaos Kanellias, Evangelos Eleutherakis-Papaiakovou, Maria Roussou, Giorgos Psarros, Efstathios Kastritis, Meletios- Athanasios Dimopoulos, Evangelos Terpos
Belantamab mafodotin, lenalidomide, and dexamethasone in transplant-ineligible patients with newly diagnosed multiple myeloma: Analysis of belantamab mafodotin-associated ocular adverse events and their impact on daily functioning from the part 1 of a phase 1/2 study. American journal of hematology (2024)
Panagiotis Malamos, Christina Papanikolaou, Maria Gavriatopoulou, Meletios- Athanasios Dimopoulos, Evangelos Terpos, Vassilis L Souliotis
The Interplay between the DNA Damage Response (DDR) Network and the Mitogen-Activated Protein Kinase (MAPK) Signaling Pathway in Multiple Myeloma. International journal of molecular sciences 25 (13) (2024)
Konstantinos Soureas, Maria-Alexandra Papadimitriou, Panagiotis Malandrakis, Aristea-Maria Papanota, Panagiotis G Adamopoulos, Ioannis Ntanasis-Stathopoulos, Christine-Ivy Liacos, Maria Gavriatopoulou, Diamantis C Sideris, Efstathios Kastritis, Meletios- Athanasios Dimopoulos, Andreas Scorilas, Evangelos Terpos, Margaritis Avgeris
Small RNA-seq and clinical evaluation of tRNA-derived fragments in multiple myeloma: Loss of mitochondrial i-tRF HisGTG results in patients' poor treatment outcome. British journal of haematology 204 (5) (2024)
Evangelos Terpos, Ioannis Ntanasis-Stathopoulos, Maria Gavriatopoulou, Eirini Katodritou, Evdoxia Hatjiharissi, Panagiotis Malandrakis, Evgenia Verrou, Stavros Golfinopoulos, Magdalini Migkou, Kyriaki Manousou, Sosana Delimpasi, Argiris Symeonidis, Efstathios Kastritis, Meletios- Athanasios Dimopoulos
Efficacy and safety of daratumumab with ixazomib and dexamethasone in lenalidomide-exposed patients after one prior line of therapy: Final results of the phase 2 study DARIA. American journal of hematology 99 (3) (2024)
Veroniki Komninaka, Pagona Flevari, Evangelia-Eleni Ntelaki, Eleni Yfanti, Theodoros Androutsakos, Ioannis Ntanasis-Stathopoulos, Evangelos Terpos
High-Oxygen-Affinity Hemoglobins-Case Series and Review of the Literature. Journal of clinical medicine 13 (2) (2024)
Panagiotis Malamos, Christina Papanikolaou, Maria Gavriatopoulou, Meletios- Athanasios Dimopoulos, Evangelos Terpos, Vassilis L Souliotis
The Interplay between the DNA Damage Response (DDR) Network and the Mitogen-Activated Protein Kinase (MAPK) Signaling Pathway in Multiple Myeloma. International journal of molecular sciences 25 (13) (2024)
Ioannis V Kostopoulos, Despina Fotiou, Maria Gavriatopoulou, Pantelis Rousakis, Ioannis Ntanasis-Stathopoulos, Chrysanthi Panteli, Panagiotis Malandrakis, Magdalini Migkou, Nikolaos Angelis, Nikolaos Kanellias, Evangelos Eleutherakis-Papaiakovou, Foteini Theodorakakou, Maria Krevvata, Evangelos Terpos, Meletios- Athanasios Dimopoulos, Ourania E Tsitsilonis, Efstathios Kastritis
Efficacy and immune modulation associated with the addition of IMiDs to Daratumumab backbone in multiple myeloma patients refractory to both drug classes: resetting synergistic activity. Blood cancer journal 14 (1) (2024)
Veroniki Komninaka, Pagona Flevari, Evangelia-Eleni Ntelaki, Eleni Yfanti, Theodoros Androutsakos, Ioannis Ntanasis-Stathopoulos, Evangelos Terpos
High-Oxygen-Affinity Hemoglobins-Case Series and Review of the Literature. Journal of clinical medicine 13 (2) (2024)
Maria Gavriatopoulou, Ioannis Ntanasis-Stathopoulos, Panagiotis Malandrakis, Despina Fotiou, Magdalini Migkou, Foteini Theodorakakou, Vasiliki Spiliopoulou, Nikolaos Kanellias, Evangelos Eleutherakis-Papaiakovou, Maria Roussou, Giorgos Psarros, Efstathios Kastritis, Meletios- Athanasios Dimopoulos, Evangelos Terpos
Belantamab mafodotin, lenalidomide, and dexamethasone in transplant-ineligible patients with newly diagnosed multiple myeloma: Analysis of belantamab mafodotin-associated ocular adverse events and their impact on daily functioning from the part 1 of a phase 1/2 study. American journal of hematology 99 (3) (2024)
Maria Papatsirou, Christos K Kontos, Ioannis Ntanasis-Stathopoulos, Panagiotis Malandrakis, Foteini Theodorakakou, Christine-Ivy Liacos, Nefeli Mavrianou-Koutsoukou, Despina Fotiou, Magdalini Migkou, Maria Gavriatopoulou, Efstathios Kastritis, Meletios- Athanasios Dimopoulos, Andreas Scorilas, Evangelos Terpos
ciRS-7 circular RNA overexpression in plasma cells is a promising molecular biomarker of unfavorable prognosis in multiple myeloma. EJHaem 5 (4) (2024)
Despina Fotiou, Foteini Theodorakakou, Maria Gavriatopoulou, Magdalini Migkou, Panagiotis Malandrakis, Ioannis Ntanasis-Stathopoulos, Nikolaos Kanellias, Evangelos Eleutherakis Papaiakovou, Evangelos Terpos, Asimina Papanikolaou, Charikleia Gakiopoulou, Meletios- Athanasios Dimopoulos, Efstathios Kastritis
Prognostic impact of translocation t(11;14) and of other cytogenetic abnormalities in patients with AL amyloidosis in the era of contemporary therapies. European journal of haematology (2023)
Vassiliki Spiliopoulou, Ioannis Ntanasis-Stathopoulos, Panagiotis Malandrakis, Maria Gavriatopoulou, Foteini Theodorakakou, Despina Fotiou, Magdalini Migkou, Maria Roussou, Evangelos Eleutherakis-Papaiakovou, Efstathios Kastritis, Meletios- Athanasios Dimopoulos, Evangelos Terpos
Use of Oral Antivirals Ritonavir-Nirmatrelvir and Molnupiravir in Patients with Multiple Myeloma Is Associated with Low Rates of Severe COVID-19: A Single-Center, Prospective Study. Viruses 15 (3) (2023)
Martina Kleber, Ioannis Ntanasis-Stathopoulos, Evangelos Terpos
The Role of t(11;14) in Tailoring Treatment Decisions in Multiple Myeloma. Cancers 15 (24) (2023)
Efstathia Liatsou, Ioannis Ntanasis-Stathopoulos, Stavros Lykos, Anastasios Ntanasis-Stathopoulos, Maria Gavriatopoulou, Theodora Psaltopoulou, Theodoros N Sergentanis, Evangelos Terpos
Adult Patients with Cancer Have Impaired Humoral Responses to Complete and Booster COVID-19 Vaccination, Especially Those with Hematologic Cancer on Active Treatment: A Systematic Review and Meta-Analysis. Cancers 15 (8) (2023)
Charalampos Filippatos, Ioannis Ntanasis-Stathopoulos, Kalliopi Sekeri, Anastasios Ntanasis-Stathopoulos, Maria Gavriatopoulou, Theodora Psaltopoulou, George Dounias, Theodoros N Sergentanis, Evangelos Terpos
Convalescent Plasma Therapy for COVID-19: A Systematic Review and Meta-Analysis on Randomized Controlled Trials. Viruses 15 (3) (2023)
Ioannis Petrakis, Christos A Kontogiorgis, Evangelia Nena, Sosana Delimpasi, Natasa E Loutsidi, Emmanouil Spanoudakis, Stergios Intzes, Christina Misidou, Marianthi Symeonidou, Nikolaos Giannakoulas, Theodoros C Constantinidis, Evangelos Terpos
Does the Simultaneous Introduction of Several Pharmaceuticals in the Post-Lenalidomide Era Translate to Better Outcomes in Relapse Refractory Multiple Myeloma? Findings from the Real-World Innovation in Multiple Myeloma (REAL IMM) Study. Cancers 15 (24) (2023)
George Simeakis, Maria C Anagnostouli, Nikolaos Fakas, John Koutsikos, Athanasios Papatheodorou, Konstantinos Chanopoulos, Kwnstantinos Athanasiou, George Papatheodorou, Evangelia Zapanti, Maria Alevizaki, Gregory Kaltsas, Evangelos Terpos
High-Dose Intravenous Steroid Treatment Seems to Have No Long-Term Negative Effect on Bone Mineral Density of Young and Newly Diagnosed Multiple Sclerosis Patients: A Pilot Study. Biomedicines 11 (2) (2023)
Efstathios Kastritis, Evangelos Terpos, Argiris Symeonidis, Vasiliki Labropoulou, Sosana Delimpasi, Katia Mancuso, Elena Zamagni, Eirini Katodritou, Elena Rivolti, Marie-Christine Kyrtsonis, Maria Roussou, Despina Fotiou, Foteini Theodorakakou, Ioannis Ntanasis-Stathopoulos, Evdoxia Hatjiharissi, Nikolaos Kanellias, Magdalini Migkou, Giorgos Cheliotis, Kyriaki Manousou, Maria Gavriatopoulou, Meletios- Athanasios Dimopoulos
Prospective phase 2 trial of daratumumab with dexamethasone in patients with relapsed/refractory multiple myeloma and severe renal impairment or on dialysis: The DARE study. American journal of hematology (2023)
Christina Zirou, Sentiljana Gumeni, Ioannis Bellos, Ioannis Ntanasis-Stathopoulos, Aimilia D Sklirou, Tina Bagratuni, Eleni Korompoki, Filia Apostolakou, Ioannis Papassotiriou, Ioannis P Trougakos, Evangelos Terpos
Longitudinal Analysis of Antibody Response Following SARS-CoV-2 Infection Depending on Disease Severity: A Prospective Cohort Study. Viruses 15 (11) (2023)
Vassiliki Spiliopoulou, Ioannis Ntanasis-Stathopoulos, Panagiotis Malandrakis, Maria Gavriatopoulou, Foteini Theodorakakou, Despina Fotiou, Magdalini Migkou, Maria Roussou, Evangelos Eleutherakis-Papaiakovou, Efstathios Kastritis, Meletios- Athanasios Dimopoulos, Evangelos Terpos
Use of Oral Antivirals Ritonavir-Nirmatrelvir and Molnupiravir in Patients with Multiple Myeloma Is Associated with Low Rates of Severe COVID-19: A Single-Center, Prospective Study. Viruses 15 (3) (2023)
Veroniki Komninaka, Pagona Flevari, Georgios Karkaletsis, Theodoros Androutsakos, Theofili Karkaletsi, Ioannis Ntanasis-Stathopoulos, Evaggelia-Eleni Ntelaki, Evangelos Terpos
Gaucher-like Cells in Thalassemia Intermedia: Is It a Challenge? Diseases (Basel, Switzerland) 11 (4) (2023)
Anastasios Tentolouris, Ioannis Ntanasis-Stathopoulos, Maria Gavriatopoulou, Ioanna Andreadou, Evangelos Terpos
Monoclonal Gammopathy of Undetermined Cardiovascular Significance; Current Evidence and Novel Insights. Journal of cardiovascular development and disease 10 (12) (2023)
Ioanna Barla, Panagiotis Efentakis, Sofia Lamprou, Maria Gavriatopoulou, Meletios- Athanasios Dimopoulos, Evangelos Terpos, Ioanna Andreadou, Νikolaos S Τhomaidis, Evangelos Gikas
Metabolomics Point out the Effects of Carfilzomib on Aromatic Amino Acid Biosynthesis and Degradation. International journal of molecular sciences 24 (18) (2023)
Ioannis Ntanasis-Stathopoulos, Charalampos Filippatos, Maria Gavriatopoulou, Panagiotis Malandrakis, Evangelos Eleutherakis-Papaiakovou, Vassiliki Spiliopoulou, Rodanthi-Eleni Syrigou, Foteini Theodorakakou, Despina Fotiou, Magdalini Migkou, Maria Roussou, Efstathios Kastritis, Meletios- Athanasios Dimopoulos, Evangelos Terpos
Tixagevimab/Cilgavimab as Pre-Exposure Prophylaxis against COVID-19 for Multiple Myeloma Patients: A Prospective Study in the Omicron Era. Diseases (Basel, Switzerland) 11 (3) (2023)
Ioannis Ntanasis-Stathopoulos, Panagiotis Malandrakis, Despina Fotiou, Magdalini Migkou, Foteini Theodorakakou, Maria Roussou, Evangelos Eleutherakis-Papaiakovou, Vassiliki Spiliopoulou, Efstathios Kastritis, Evangelos Terpos, Meletios- Athanasios Dimopoulos, Maria Gavriatopoulou
Real-World Effectiveness and Safety of Belantamab Mafodotin Monotherapy in Triple-Class Refractory Multiple Myeloma. International journal of molecular sciences 24 (14) (2023)
Eirini Katodritou, Efstathios Kastritis, Dimitra Dalampira, Sosana Delimpasi, Emmanouil Spanoudakis, Vasiliki Labropoulou, Ioannis Ntanasis-Stathopoulos, Annita-Ioanna Gkioka, Nikos Giannakoulas, Nikolaos Kanellias, Theodosia Papadopoulou, Aggeliki Sevastoudi, Eyrydiki Michalis, Maria Papathanasiou, Maria Kotsopoulou, Anastasia Sioni, Theodora Triantafyllou, Aikaterini Daiou, Mavra Papadatou, Marie-Christine Kyrtsonis, Anastasia Pouli, Ioannis V Kostopoulos, Evgenia Verrou, Meletios- Athanasios Dimopoulos, Evangelos Terpos
Improved survival of patients with primary plasma cell leukemia with VRd or daratumumab-based quadruplets: A multicenter study by the Greek myeloma study group. American journal of hematology (2023)
Maria Geropeppa, Ioanna Papadatou, Panagiotis Sarantis, Marianna Tzanoudaki, Ioannis Ntanasis-Stathopoulos, Tina Bagratuni, Evangelos Terpos, Vana Spoulou
Receptor-Binding-Domain-Specific B Cell Responses Induced by mRNA Immunization against SARS-CoV-2. Vaccines 11 (7) (2023)
Anastasios Tentolouris, Ioannis Ntanasis-Stathopoulos, Maria Gavriatopoulou, Ioanna Andreadou, Evangelos Terpos
Monoclonal Gammopathy of Undetermined Cardiovascular Significance; Current Evidence and Novel Insights. Journal of cardiovascular development and disease 10 (12) (2023)
Vassiliki Spiliopoulou, Ioannis Ntanasis-Stathopoulos, Panagiotis Malandrakis, Maria Gavriatopoulou, Foteini Theodorakakou, Despina Fotiou, Magdalini Migkou, Maria Roussou, Evangelos Eleutherakis-Papaiakovou, Efstathios Kastritis, Meletios- Athanasios Dimopoulos, Evangelos Terpos
Use of Oral Antivirals Ritonavir-Nirmatrelvir and Molnupiravir in Patients with Multiple Myeloma Is Associated with Low Rates of Severe COVID-19: A Single-Center, Prospective Study. Viruses 15 (3) (2023)
Evangelos Terpos, Pellegrino Musto, Monika Engelhardt, Michel Delforge, Curly T C M Morris, Francesca Gay, Niels W C J van de Donk, Ioannis Ntanasis-Stathopoulos, Annette Juul Vangsted, Christoph Driessen, Schjesvold Fredrik, Claudio Cerchione, Sonja Zweegman, Roman Hájek, Phillipe Moreau, Hermann Einsele, Jesús San F Miguel, Mario Boccadoro, Meletios- Athanasios Dimopoulos, Pieter Sonneveld, Heinz Ludwig
Management of patients with multiple myeloma and COVID-19 in the post pandemic era: a consensus paper from the European Myeloma Network (EMN). Leukemia (2023)
George Simeakis, Maria C Anagnostouli, Nikolaos Fakas, John Koutsikos, Athanasios Papatheodorou, Konstantinos Chanopoulos, Kwnstantinos Athanasiou, George Papatheodorou, Evangelia Zapanti, Maria Alevizaki, Gregory Kaltsas, Evangelos Terpos
High-Dose Intravenous Steroid Treatment Seems to Have No Long-Term Negative Effect on Bone Mineral Density of Young and Newly Diagnosed Multiple Sclerosis Patients: A Pilot Study. Biomedicines 11 (2) (2023)
Evangelos Terpos, Pellegrino Musto, Monika Engelhardt, Michel Delforge, Curly T C M Morris, Francesca Gay, Niels W C J van de Donk, Ioannis Ntanasis-Stathopoulos, Annette Juul Vangsted, Christoph Driessen, Schjesvold Fredrik, Claudio Cerchione, Sonja Zweegman, Roman Hájek, Phillipe Moreau, Hermann Einsele, Jesús San F Miguel, Mario Boccadoro, Meletios- Athanasios Dimopoulos, Pieter Sonneveld, Heinz Ludwig
Management of patients with multiple myeloma and COVID-19 in the post pandemic era: a consensus paper from the European Myeloma Network (EMN). Leukemia (2023)
Efstathia Liatsou, Ioannis Ntanasis-Stathopoulos, Stavros Lykos, Anastasios Ntanasis-Stathopoulos, Maria Gavriatopoulou, Theodora Psaltopoulou, Theodoros N Sergentanis, Evangelos Terpos
Adult Patients with Cancer Have Impaired Humoral Responses to Complete and Booster COVID-19 Vaccination, Especially Those with Hematologic Cancer on Active Treatment: A Systematic Review and Meta-Analysis. Cancers 15 (8) (2023)
Efthymia Skafida, Angeliki Andrikopoulou, Evangelos Terpos, Christos Markellos, Savvina Moustafa, Dimitrios Pectasides, Meletios- Athanasios Dimopoulos, Flora Zagouri, Dimitrios Vassilopoulos
Impact of CDK4/6 Inhibitors on Aromatase Inhibitor-Associated Musculoskeletal Syndrome (AIMSS) in the Adjuvant Setting. The breast journal 2023 (2023)
Martina Kleber, Ioannis Ntanasis-Stathopoulos, Evangelos Terpos
The Role of t(11;14) in Tailoring Treatment Decisions in Multiple Myeloma. Cancers 15 (24) (2023)
Maria-Alexandra Papadimitriou, Konstantinos Soureas, Aristea-Maria Papanota, Panagiotis Tsiakanikas, Panagiotis G Adamopoulos, Ioannis Ntanasis-Stathopoulos, Panagiotis Malandrakis, Maria Gavriatopoulou, Diamantis C Sideris, Efstathios Kastritis, Margaritis Avgeris, Meletios-Athanasios Dimopoulos, Evangelos Terpos, Andreas Scorilas
miRNA-seq identification and clinical validation of CD138+ and circulating miR-25 in treatment response of multiple myeloma. Journal of translational medicine 21 (1) (2023)
Foteini Theodorakakou, Despina Fotiou, Vasiliki Spiliopoulou, Maria Roussou, Panagiotis Malandrakis, Ioannis Ntanasis-Stathopoulos, Magdalini Migkou, Evangelos Eleutherakis-Papaiakovou, Nikolaos Kanellias, Asimina Papanikolaou, Maria Gavriatopoulou, Evangelos Terpos, Meletios- Athanasios Dimopoulos, Efstathios Kastritis
Outcomes of patients with light chain (AL) amyloidosis after failure of daratumumab-based therapy. British journal of haematology (2023)
Evangelos Terpos, Pellegrino Musto, Monika Engelhardt, Ioannis Ntanasis-Stathopoulos, Pieter Sonneveld, Heinz Ludwig
Convalescent plasma for patients with multiple myeloma and COVID-19; the European Myeloma Network consensus. Leukemia (2023)
Santhi Devasundaram, Evangelos Terpos, Margherita Rosati, Ioannis Ntanasis-Stathopoulos, Jenifer Bear, Robert Burns, Stamatia Skourti, Panagiotis Malandrakis, Ioannis P Trougakos, Meletios- Athanasios Dimopoulos, George N Pavlakis, Barbara K Felber
XBB.1.5 neutralizing antibodies upon bivalent COVID-19 vaccination are similar to XBB but lower than BQ.1.1. American journal of hematology (2023)
Santhi Devasundaram, Evangelos Terpos, Margherita Rosati, Ioannis Ntanasis-Stathopoulos, Jenifer Bear, Robert Burns, Stamatia Skourti, Panagiotis Malandrakis, Ioannis P Trougakos, Meletios- Athanasios Dimopoulos, George N Pavlakis, Barbara K Felber
XBB.1.5 neutralizing antibodies upon bivalent COVID-19 vaccination are similar to XBB but lower than BQ.1.1. American journal of hematology (2023)
Charalampos Filippatos, Ioannis Ntanasis-Stathopoulos, Kalliopi Sekeri, Anastasios Ntanasis-Stathopoulos, Maria Gavriatopoulou, Theodora Psaltopoulou, George Dounias, Theodoros N Sergentanis, Evangelos Terpos
Convalescent Plasma Therapy for COVID-19: A Systematic Review and Meta-Analysis on Randomized Controlled Trials. Viruses 15 (3) (2023)
Charalampos Filippatos, Ioannis Ntanasis-Stathopoulos, Kalliopi Sekeri, Anastasios Ntanasis-Stathopoulos, Maria Gavriatopoulou, Theodora Psaltopoulou, George Dounias, Theodoros N Sergentanis, Evangelos Terpos
Convalescent Plasma Therapy for COVID-19: A Systematic Review and Meta-Analysis on Randomized Controlled Trials. Viruses 15 (3) (2023)
Eirini Katodritou, Efstathios Kastritis, Dimitra Dalampira, Sosana Delimpasi, Emmanouil Spanoudakis, Vasiliki Labropoulou, Ioannis Ntanasis-Stathopoulos, Annita-Ioanna Gkioka, Nikos Giannakoulas, Nikolaos Kanellias, Theodosia Papadopoulou, Aggeliki Sevastoudi, Eyrydiki Michalis, Maria Papathanasiou, Maria Kotsopoulou, Anastasia Sioni, Theodora Triantafyllou, Aikaterini Daiou, Mavra Papadatou, Marie-Christine Kyrtsonis, Anastasia Pouli, Ioannis V Kostopoulos, Evgenia Verrou, Meletios- Athanasios Dimopoulos, Evangelos Terpos
Improved Survival of Patients with Primary Plasma Cell Leukemia with VRd or Daratumumab-based Quadruplets: A Multicenter Study by the Greek Myeloma Study Group. American journal of hematology (2023)
Ioannis Petrakis, Christos A Kontogiorgis, Evangelia Nena, Sosana Delimpasi, Natasa E Loutsidi, Emmanouil Spanoudakis, Stergios Intzes, Christina Misidou, Marianthi Symeonidou, Nikolaos Giannakoulas, Theodoros C Constantinidis, Evangelos Terpos
Does the Simultaneous Introduction of Several Pharmaceuticals in the Post-Lenalidomide Era Translate to Better Outcomes in Relapse Refractory Multiple Myeloma? Findings from the Real-World Innovation in Multiple Myeloma (REAL IMM) Study. Cancers 15 (24) (2023)
Anastasios Tentolouris, Ioannis Ntanasis-Stathopoulos, Maria Gavriatopoulou, Ioanna Andreadou, Evangelos Terpos
Monoclonal Gammopathy of Undetermined Cardiovascular Significance; Current Evidence and Novel Insights. Journal of cardiovascular development and disease 10 (12) (2023)
Anastasios I Birmpilis, Antonios Paschalis, Apostolis Mourkakis, Panayiota Christodoulou, Ioannis V Kostopoulos, Elina Antimissari, Georgia I Terzoudi, Alexandros G Georgakilas, Christina Armpilia, Panagiotis Papageorgis, Efstathios Kastritis, Evangelos Terpos, Meletios- Athanasios Dimopoulos, Hubert Kalbacher, Evangelia Livaniou, Maria-Ioanna Christodoulou, Ourania E Tsitsilonis
Immunogenic Cell Death, DAMPs and Prothymosin α as a Putative Anticancer Immune Response Biomarker. Cells 11 (9) (2022)
Ioanna Barla, Panagiotis Efentakis, Sofia Lamprou, Maria Gavriatopoulou, Meletios- Athanasios Dimopoulos, Evangelos Terpos, Ioanna Andreadou, Νikolaos S Τhomaidis, Evangelos Gikas
An Untargeted Metabolomics Approach on Carfilzomib-Induced Nephrotoxicity. Molecules (Basel, Switzerland) 27 (22) (2022)
Efstathios Kastritis, Magdalini Migkou, Dimitra Dalampira, Maria Gavriatopoulou, Despina Fotiou, Maria Roussou, Nikolaos Kanellias, Ioannis Ntanasis-Stathopoulos, Panagiotis Malandrakis, Foteini Theodorakakou, Aggeliki Sevastoudi, Evangelos Eleutherakis-Papaiakovou, Theodora Triantafyllou, Evangelos Terpos, Eirini Katodritou, Meletios- Athanasios Dimopoulos
Chromosome 1q21 aberrations identify ultra high-risk myeloma with prognostic and clinical implications. American journal of hematology 97 (9) (2022)
Ioannis V Kostopoulos, Antonis Kakalis, Anastasios Birmpilis, Nikolaos Angelis, Nikolaos Orologas-Stavrou, Pantelis Rousakis, Chrysanthi Panteli, Maria Gavriatopoulou, Efstathios Kastritis, Meletios- Athanasios Dimopoulos, Ourania Tsitsilonis, Evangelos Terpos
Belantamab mafodotin induces immunogenic cell death within 24 h post-administration in newly diagnosed multiple myeloma patients. American journal of hematology 98 (3) (2022)
Margherita Rosati, Evangelos Terpos, Jenifer Bear, Robert Burns, Santhi Devasundaram, Ioannis Ntanasis-Stathopoulos, Maria Gavriatopoulou, Efstathios Kastritis, Meletios- Athanasios Dimopoulos, George N Pavlakis, Barbara K Felber
Low Spike Antibody Levels and Impaired BA.4/5 Neutralization in Patients with Multiple Myeloma or Waldenstrom's Macroglobulinemia after BNT162b2 Booster Vaccination. Cancers 14 (23) (2022)
Stavroula Labropoulou, Niki Vassilaki, Raphaela S Milona, Evangelos Terpos, Marianna Politou, Vasiliki Pappa, Maria Pagoni, Elisavet Grouzi, Meletios- Athanasios Dimopoulos, Andreas Mentis, Mary Emmanouil, Emmanouil Angelakis
Characterizing Kinetics and Avidity of SARS-CoV-2 Antibody Responses in COVID-19 Greek Patients. Viruses 14 (4) (2022)
Flora Zagouri, Alkistis Papatheodoridi, Michalis Liontos, Alexandros Briasoulis, Aimilia D Sklirou, Efthymia Skafida, Oraianthi Fiste, Christos Markellos, Angeliki Andrikopoulou, Konstantinos Koutsoukos, Maria Kaparelou, Eirini Gkogkou, Ioannis P Trougakos, Meletios- Athanasios Dimopoulos, Evangelos Terpos
Assessment of Postvaccination Neutralizing Antibodies Response against SARS-CoV-2 in Cancer Patients under Treatment with Targeted Agents. Vaccines 10 (9) (2022)
Vassilis Koutoulidis, Evangelos Terpos, Nickolas Papanikolaou, Sophia Fontara, Ioannis Seimenis, Maria Gavriatopoulou, Ioannis Ntanasis-Stathopoulos, Charis Bourgioti, João Santinha, José Maria Moreira, Efstathios Kastritis, Meletios- Athanasios Dimopoulos, Lia Angela Moulopoulos
Comparison of MRI Features of Fat Fraction and ADC for Early Treatment Response Assessment in Participants with Multiple Myeloma. Radiology 304 (1) (2022)
Evangelos Terpos, Michalis Liontos, Oraianthi Fiste, Flora Zagouri, Alexandros Briasoulis, Aimilia D Sklirou, Christos Markellos, Efthymia Skafida, Alkistis Papatheodoridi, Angeliki Andrikopoulou, Konstantinos Koutsoukos, Maria Kaparelou, Vassiliki A Iconomidou, Ioannis P Trougakos, Meletios- Athanasios Dimopoulos
SARS-CoV-2 Neutralizing Antibodies Kinetics Postvaccination in Cancer Patients under Treatment with Immune Checkpoint Inhibition. Cancers 14 (11) (2022)
Katja Weisel, Ajay K Nooka, Evangelos Terpos, Andrew Spencer, Hartmut Goldschmidt, Franziska Dirnberger, Lucy DeCosta, Akeem Yusuf, Shaji K Kumar
Carfilzomib 56 mg/m 2 twice-weekly in combination with dexamethasone and daratumumab (KdD) versus daratumumab in combination with bortezomib and dexamethasone (DVd): a matching-adjusted indirect treatment comparison. Leukemia & lymphoma 63 (8) (2022)
Margherita Rosati, Evangelos Terpos, Jenifer Bear, Robert Burns, Santhi Devasundaram, Ioannis Ntanasis-Stathopoulos, Maria Gavriatopoulou, Efstathios Kastritis, Meletios- Athanasios Dimopoulos, George N Pavlakis, Barbara K Felber
Low Spike Antibody Levels and Impaired BA.4/5 Neutralization in Patients with Multiple Myeloma or Waldenstrom's Macroglobulinemia after BNT162b2 Booster Vaccination. Cancers 14 (23) (2022)
Xavier Leleu, Eirini Katodritou, Thomas Kuehr, Evangelos Terpos, Jo Caers, Renato Zambello, Alessandra Brescianini, Tony Liang, Sally Wetten, Sorina Nicoleta Bădeliţă
Real-world use of carfilzomib combined with lenalidomide and dexamethasone in patients with multiple myeloma in Europe and Israel. EJHaem 4 (1) (2022)
Georgia Trakada, Despina Fotiou, Anastasios Kallianos, Foteini Theodorakakou, Magdalini Migkou, Maria Gavriatopoulou, Nikolaos Kanellias, Panagiotis Malandrakis, Ioannis Ntanasis-Stathopoulos, Evangelos Eleutherakis-Papaiakovou, Ioanna Dialoupi, Evangelos Terpos, Meletios- Athanasios Dimopoulos, Efstathios Kastritis
Pulmonary function tests reveal unrecognised lung dysfunction and have independent prognostic significance in patients with systemic AL amyloidosis. Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis (2022)
Evangelos Terpos, Vangelis D Karalis, Ioannis Ntanasis-Stathopoulos, Zoi Evangelakou, Maria Gavriatopoulou, Maria S Manola, Panagiotis Malandrakis, Despoina D Gianniou, Efstathios Kastritis, Ioannis P Trougakos, Meletios- Athanasios Dimopoulos
Comparison of Neutralizing Antibody Responses at 6 Months Post Vaccination with BNT162b2 and AZD1222. Biomedicines 10 (2) (2022)
Dimitris Papadopoulos, Ioannis Ntanasis-Stathopoulos, Maria Gavriatopoulou, Zoi Evangelakou, Panagiotis Malandrakis, Maria S Manola, Despoina D Gianniou, Efstathios Kastritis, Ioannis P Trougakos, Meletios- Athanasios Dimopoulos, Vangelis D Karalis, Evangelos Terpos
Predictive Factors for Neutralizing Antibody Levels Nine Months after Full Vaccination with BNT162b2: Results of a Machine Learning Analysis. Biomedicines 10 (2) (2022)
Stefanos I Papadhimitriou, Evangelos Terpos, Konstantinos Liapis, Dimitrios Pavlidis, Theodoros Marinakis, Efstathios Kastritis, Meletios- Athanasios Dimopoulos, Ourania E Tsitsilonis, Ioannis V Kostopoulos
The Cytogenetic Profile of Primary and Secondary Plasma Cell Leukemia: Etiopathogenetic Perspectives, Prognostic Impact and Clinical Relevance to Newly Diagnosed Multiple Myeloma with Differential Circulating Clonal Plasma Cells. Biomedicines 10 (2) (2022)
Ioannis V Kostopoulos, Antonis Kakalis, Anastasios Birmpilis, Nikolaos Angelis, Nikolaos Orologas-Stavrou, Pantelis Rousakis, Chrysanthi Panteli, Maria Gavriatopoulou, Efstathios Kastritis, Meletios- Athanasios Dimopoulos, Ourania Tsitsilonis, Evangelos Terpos
Belantamab mafodotin induces immunogenic cell death within 24 h post-administration in newly diagnosed multiple myeloma patients. American journal of hematology (2022)
Rosalinda Termini, David Zihala, Evangelos Terpos, Albert Perez-Montaña, Tomas Jelinek, Marc-Steffen Raab, Niels Weinhold, Elias Karl Mai, Anna Luise Grab, Jill Corre, François Vergez, Antonio Sacco, Marco Chiarini, Viviana Giustini, Alessandra Tucci, Sara Rodriguez, Cristina Moreno, Cristina Perez, Catarina Maia, Esperanza Martin-Sanchez, Camilla Guerrero, Cirino Botta, Juan-José Garcés, Aitziber Lopez, Luis Esteban Tamariz-Amador, Felipe Prosper, Joan Bargay, Maria-Elena Cabezudo, Enrique María Ocio, Roman Hájek, Joaquin Martinez Lopez, Fernando Solano, Rebeca Iglesias, Artur Paiva, Catarina Geraldes, Helena Vitoria, Clara Gomez, Felipe De Arriba, Heinz Ludwig, Antoni Garcia-Guiñon, María Casanova, Adrian Alegre, Valentín Cabañas, Maialen Sirvent, Albert Ortiol, Javier de la Rubia, Jose-Ángel Hernández-Rivas, Luis Palomera, Maria Sarasa, Pablo Rios, Noemi Puig, Maria-Victoria Mateos-Manteca, Juan A Flores-Montero, Alberto Orfao, Hartmut Goldschmidt, Herve Avet-Loiseau, Aldo M Roccaro, Jesús San F Miguel, Juan José Lahuerta, null null
Circulating Tumor and Immune Cells for Minimally Invasive Risk Stratification of Smoldering Multiple Myeloma. Clinical cancer research : an official journal of the American Association for Cancer Research 28 (21) (2022)
Nikolaos Kanellias, Ioannis Ntanasis-Stathopoulos, Maria Gavriatopoulou, Vassilis Koutoulidis, Despina Fotiou, Magdalini Migkou, Evangelos Eleutherakis-Papaiakovou, Panagiotis Malandrakis, Tina Bagratuni, Stylianos Mavropoulos-Papoudas, Maria Roussou, Efstathios Kastritis, Lia A Moulopoulos, Meletios- Athanasios Dimopoulos, Evangelos Terpos
Newly Diagnosed Multiple Myeloma Patients with Skeletal-Related Events and Abnormal MRI Pattern Have Poor Survival Outcomes: A Prospective Study on 370 Patients. Journal of clinical medicine 11 (11) (2022)
Evangelos Terpos, Renato Zambello, Xavier Leleu, Thomas Kuehr, Sorina N Badelita, Eirini Katodritou, Alessandra Brescianini, Tony Liang, Sally Wetten, Jo Caers
Real-World Use and Effectiveness of Carfilzomib Plus Dexamethasone in Relapsed/Refractory Multiple Myeloma in Europe. Cancers 14 (21) (2022)
Maria Gkotzamanidou, Evangelos Terpos, Meletios- Athanasios Dimopoulos, Vassilis L Souliotis
The Combination of Panobinostat and Melphalan for the Treatment of Patients with Multiple Myeloma. International journal of molecular sciences 23 (24) (2022)
Margherita Rosati, Evangelos Terpos, Jenifer Bear, Robert Burns, Santhi Devasundaram, Ioannis Ntanasis-Stathopoulos, Maria Gavriatopoulou, Efstathios Kastritis, Meletios- Athanasios Dimopoulos, George N Pavlakis, Barbara K Felber
Low Spike Antibody Levels and Impaired BA.4/5 Neutralization in Patients with Multiple Myeloma or Waldenstrom's Macroglobulinemia after BNT162b2 Booster Vaccination. Cancers 14 (23) (2022)
Evangelos Terpos, Vangelis Karalis, Aimilia D Sklirou, Filia Apostolakou, Ioannis Ntanasis-Stathopoulos, Tina Bagratuni, Vassiliki A Iconomidou, Panagiotis Malandrakis, Eleni Korompoki, Ioannis Papassotiriou, Ioannis P Trougakos, Meletios- Athanasios Dimopoulos
Third dose of the BNT162b2 vaccine results in very high levels of neutralizing antibodies against SARS-CoV-2: Results of a prospective study in 150 health professionals in Greece. American journal of hematology 97 (4) (2022)
Maria Gkotzamanidou, Evangelos Terpos, Meletios- Athanasios Dimopoulos, Vassilis L Souliotis
The Combination of Panobinostat and Melphalan for the Treatment of Patients with Multiple Myeloma. International journal of molecular sciences 23 (24) (2022)
Evangelos Terpos, Meletios- Athanasios Dimopoulos, Mario Boccadoro, Sosana Delimpasi, Meral Beksac, Eirini Katodritou, Phillipe Moreau, Alessandra Pompa, Argiris Symeonidis, Jelena Bila, Albert Oriol, Maria-Victoria Mateos, Hermann Einsele, Ioannis Orfanidis, Katharine S Gries, John Fastenau, Kevin Liu, Jianming He, Tobias Kampfenkel, Yanping Qiu, Himal Amin, Robin Carson, Pieter Sonneveld
Health-related quality of life in patients with relapsed/refractory multiple myeloma treated with pomalidomide and dexamethasone ± subcutaneous daratumumab: Patient-reported outcomes from the APOLLO trial. American journal of hematology 97 (4) (2022)
Dionysios Palermos, Theodoros N Sergentanis, Maria Gavriatopoulou, Panagiotis Malandrakis, Theodora Psaltopoulou, Evangelos Terpos, Ioannis Ntanasis-Stathopoulos
Lung Cancer Clinical Trials with a Seamless Phase II/III Design: Systematic Review. Journal of clinical medicine 11 (23) (2022)
Ioannis V Kostopoulos, Antonis Kakalis, Anastasios Birmpilis, Nikolaos Angelis, Nikolaos Orologas-Stavrou, Pantelis Rousakis, Chrysanthi Panteli, Maria Gavriatopoulou, Efstathios Kastritis, Meletios- Athanasios Dimopoulos, Ourania Tsitsilonis, Evangelos Terpos
Belantamab mafodotin induces immunogenic cell death within 24 hours post administration in newly diagnosed multiple myeloma patients. American journal of hematology (2022)
Evangelos Terpos, Ioannis Ntanasis-Stathopoulos, Efstathios Kastritis, Evdoxia Hatjiharissi, Eirini Katodritou, Evangelos Eleutherakis-Papaiakovou, Evgenia Verrou, Maria Gavriatopoulou, Alexandros Leonidakis, Kyriaki Manousou, Sosana Delimpasi, Panagiotis Malandrakis, Marie-Christine Kyrtsonis, Maria Papaioannou, Argiris Symeonidis, Meletios- Athanasios Dimopoulos
Daratumumab Improves Bone Turnover in Relapsed/Refractory Multiple Myeloma; Phase 2 Study "REBUILD". Cancers 14 (11) (2022)
Dionysios Palermos, Theodoros N Sergentanis, Maria Gavriatopoulou, Panagiotis Malandrakis, Theodora Psaltopoulou, Evangelos Terpos, Ioannis Ntanasis-Stathopoulos
Lung Cancer Clinical Trials with a Seamless Phase II/III Design: Systematic Review. Journal of clinical medicine 11 (23) (2022)
Ioanna Dagla, Aikaterini Iliou, Dimitra Benaki, Evangelos Gikas, Emmanuel Mikros, Tina Bagratuni, Efstathios Kastritis, Meletios- Athanasios Dimopoulos, Evangelos Terpos, Anthony Tsarbopoulos
Plasma Metabolomic Alterations Induced by COVID-19 Vaccination Reveal Putative Biomarkers Reflecting the Immune Response. Cells 11 (7) (2022)
Ioannis V Kostopoulos, Antonis Kakalis, Anastasios Birmpilis, Nikolaos Angelis, Nikolaos Orologas-Stavrou, Pantelis Rousakis, Chrysanthi Panteli, Maria Gavriatopoulou, Efstathios Kastritis, Meletios- Athanasios Dimopoulos, Ourania Tsitsilonis, Evangelos Terpos
Belantamab mafodotin induces immunogenic cell death within 24 h post-administration in newly diagnosed multiple myeloma patients. American journal of hematology 98 (3) (2022)
Eugenia Gkaliagkousi, Dimitra Dalampira, Foteini Theodorakakou, Christine-Ivy Liacos, Nikolaos Kanellias, Evangelos Eleutherakis-Papaiakovou, Evangelos Terpos, Maria Gavriatopoulou, Evgenia Verrou, Theodora Triantafyllou, Aggeliki Sevastoudi, Evaggelia-Evdoxia Koravou, Tasoula Touloumenidou, Christos Varelas, Apostolia Papalexandri, Ioanna Sakellari, Meletios- Athanasios Dimopoulos, Efstathios Kastritis, Eirini Katodritou
Genetic and Functional Evidence of Complement Dysregulation in Multiple Myeloma Patients with Carfilzomib-Induced Thrombotic Microangiopathy Compared to Controls. Journal of clinical medicine 11 (12) (2022)
Ioannis V Kostopoulos, Ioannis Ntanasis-Stathopoulos, Pantelis Rousakis, Evangelos Eleutherakis-Papaiakovou, Chrysanthi Panteli, Panagiotis Malandrakis, Nikolaos Angelis, Nikolaos Kanellias, Nikolaos Orologas-Stavrou, Aristea-Maria Papanota, Despina Fotiou, Magdalini Migkou, Maria Gavriatopoulou, Efstathios Kastritis, Ourania Tsitsilonis, Evangelos Terpos, Meletios- Athanasios Dimopoulos
Circulating Plasma Cells in Newly Diagnosed Multiple Myeloma: Prognostic and More. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2022)
Efstathios Kastritis, Evangelos Terpos, Meletios- Athanasios Dimopoulos
How I treat relapsed multiple myeloma. Blood 139 (19) (2022)
Ioannis V Kostopoulos, Antonis Kakalis, Anastasios Birmpilis, Nikolaos Angelis, Nikolaos Orologas-Stavrou, Pantelis Rousakis, Chrysanthi Panteli, Maria Gavriatopoulou, Efstathios Kastritis, Meletios- Athanasios Dimopoulos, Ourania Tsitsilonis, Evangelos Terpos
Belantamab mafodotin induces immunogenic cell death within 24 h post-administration in newly diagnosed multiple myeloma patients. American journal of hematology 98 (3) (2022)
Xavier Leleu, Eirini Katodritou, Thomas Kuehr, Evangelos Terpos, Jo Caers, Renato Zambello, Alessandra Brescianini, Tony Liang, Sally Wetten, Sorina Nicoleta Bădeliţă
Real-world use of carfilzomib combined with lenalidomide and dexamethasone in patients with multiple myeloma in Europe and Israel. EJHaem 4 (1) (2022)
Ioannis V Kostopoulos, Antonis Kakalis, Anastasios Birmpilis, Nikolaos Angelis, Nikolaos Orologas-Stavrou, Pantelis Rousakis, Chrysanthi Panteli, Maria Gavriatopoulou, Efstathios Kastritis, Meletios- Athanasios Dimopoulos, Ourania Tsitsilonis, Evangelos Terpos
Belantamab mafodotin induces immunogenic cell death within 24 h post-administration in newly diagnosed multiple myeloma patients. American journal of hematology 98 (3) (2022)
Maria Gkotzamanidou, Evangelos Terpos, Meletios- Athanasios Dimopoulos, Vassilis L Souliotis
The Combination of Panobinostat and Melphalan for the Treatment of Patients with Multiple Myeloma. International journal of molecular sciences 23 (24) (2022)

Evangelos Terpos.css-eqlu8i{font-size:small;padding-left:4px;} (E Terpos)

Publication Activity (10 Years)

Top Topics

Top Venues

Evangelos Terpos (E Terpos)